We would love to hear your thoughts about our site and services, please take our survey here.
"...sponsors could use this biomarker data to design registrational phase 3 studies that can enroll a more ****geneous patient population, potentially leading to better study outcomes and ultimately u.s. food and drug administration (fda) approval."
Tommoclarke
This subject is very contentious.
But I prefer to go off national statistics.
https://blog.ons.gov.uk/2022/01/26/to-say-only-17000-people-have-died-from-covid-19-is-highly-misleading/
Do not ask for investment advice on a annanomous bb. It is a recipe for disaster. Many just plunged into this share on a spike hoping to be overnight millionaires. Pharma type stocks are very high risk. Do not invest if you are not prepared to lose every last penny.
Professional
Yes I will be there I will be wearing an orange badge that says "I love Synairgen".
Yes I agree with you for once they will do a Q&A.
I also believe we will get some good news next week. Not what we all want but it will give the share price a nice boost. They will give full details on the 3 trials they have been planning.
Well I have been busy buying cheap shares. I now need 34p to break even. Will it get to 34p, yes of course it will and above very soon. Will I sell at that? It all depends on what is announced for trials in H2. Like others I'm very annoyed at what has happened but you need sn exit strategy and I have mine now if needed.
The filings seem upto date on the Gov.uk site.
https://find-and-update.company-information.service.gov.uk/company/04793696/filing-history
So are they upsizing or downsizing?
https://www.rightmove.co.uk/properties/96636523#/?channel=COM_LET